Remove 2024 Remove Pharmacokinetics Remove Protein Expression
article thumbnail

Five Promising Treatment Areas in Early-Phase Drug Development in 2024

Alta Sciences

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

article thumbnail

FDA’s Project Optimus: A new era in oncology drug dosing

Drug Target Review

Molecular factors Molecular markers, such as protein expression and signalling pathway activation, also guide therapy choices. For example, PD-L1 expression predicts the response to immune checkpoint inhibitors. This approach underlies the identification of the OBD, backed by both clinical efficacy and drug tolerability data.